Life Cycle in Medicine

Welcome to the graduate programme Life Cycle in Medicine.

This graduate programme encompasses all aspects of normal and disordered development in the fetus, child, and adolescent and its role in health through-out life. Understanding the development and the presentation of specific diseases in children and teenagers and how it translates into adult and senescence health requires detailed knowledge on the developmental plasticity and vulnerability in the developing body.

Congenital diseases may present at birth or throughout postnatal life and require medical assistance in childhood as well as in adult life. Many fetal and childhood-onset diseases and their treatment have lifelong consequences and late effects in adult life. Conversely, many adult-onset diseases may have a fetal origin. Reproductive diseases are also associated with health in later life.

Knowledge on normal development in all phases of the life cycle is important to understand the pathogenesis and pathophysiology of the diseases, to optimize age-dependent diagnostic and therapeutic options, and to study the impact of disease and its treatment throughout life; from fetal to adult life. Hence the acronym; Life Cycle in Medicine.

• Fetal growth restriction (IUGR)
• Congenital malformations (e.g. DSD, cardiac anomalies)
• Postnatal growth and puberty disorders (e.g. growth hormone disorders
• Skeletal dysplasia, precocious puberty and hypogonadism)
• Pregnancy-associated disorders (e.g. pre-eclampsia, gestational diabetes) and obstetric complications
• Neonatology (e.g. prematurity)
• Paediatric surgery
• Acute and chronic paediatric diseases (e.g. cancer, pulmonology, autoimmune, and inflammatory and infectious disorders in children and adolescents)
• Paediatric pharmacology
• Late effects of childhood diseases
• Gynaecological disorders (e.g. ovarian disorders, cancer, endometriosis, recurrent pregnancy loss)
• Gender dysphoria, male and female reproductive disorders (e.g. impaired spermatogenesis, PCOS)
• Assisted reproductive techniques (e.g. ICSI, long-term follow up of ART children)
• Immunology and microbiome impact on implantation and early pregnancy
• Endocrine diseases (e.g. hypothalamic, pituitary, adrenal, thyroid, bone disorders)
• Misuse of anabolic steroids
• Non-classical endocrine cross-talks and endocrine-disrupters

• Anders Juul, professor, growth and reproduction, Rigshospitalet
• Anja Pinborg, professor, fertility, Rigshospitalet
• Anna-Maria Andersson, research director, growth and reproduction, Rigshospitalet
• Caroline Kistorp, professor, endocrinology, Rigshospitalet
• Dina Cortes, professor, paediatrics, Amager-Hvidovre Hospital
• Gorm Greisen, professor, paediatrics, Rigshospitalet
• Hanne Kristine Hegaard, Midwife, associate professor, obstetrics, Rigshospitalet
• Henriette Svarre Nielsen, associate professor, reproductive immunology, Rigshospitalet
• Katharina Main, professor, paediatrics, Head of graduate programme, Rigshospitalet
• Kjeld Schmiegelow, professor, paediatrics, Rigshospitalet
• Klaus Bønnelykke, associate professor, paediatrics, Herlev/Gentofte Hospital
• Pernille Badsberg Norup, PhD student, growth and reproduction, Rigshospitalet
• Rikke Beck Jensen, consultant, PhD coordinator, Juliane Marie Centre
• Øjvind Lidegaard, representing professor, gynaecology, Rigshospitalet

Head of graduate programme: Professor Katharina Maria Main

Graduate programme secretariat Kathrine D. Hurtigkarl

Klinik for Vækst og Reproduktion
Rigshospitalet
Blegdamsvej 9
2100 København Ø
Phone: 3545 5085
E-mail: Kathrine.Dahl.Hurtigkarl@regionh.dk

Life Cycle in Medicine University of Copenhagen | Facebook